Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.97	6.07	9.29	13.52	15.19	11.67
Short-Term Investments	3.08	8.2	10.49	26.37	45.98	0.02
Cash & Short-Term Investments	10.06	14.27	19.78	39.89	61.16	11.7
Cash Growth	-48.11%	-27.89%	-50.41%	-34.77%	422.83%	-4.58%
Other Receivables	1.72	0.26	0.29	0.46	0.18	0.07
Receivables	1.72	0.26	0.29	0.46	0.18	0.07
Prepaid Expenses	-	1.44	0.75	1.31	1.35	0.07
Restricted Cash	0.15	0.08	0.08	0.08	-	-
Total Current Assets	11.93	16.04	20.9	41.74	62.69	11.84
Property, Plant & Equipment	0.19	0.54	0.7	0.59	0.7	0.58
Other Long-Term Assets	0.25	0.39	0.56	0.73	0.96	0.06
Total Assets	12.37	16.96	22.15	43.06	64.35	12.48
Accounts Payable	0.19	0.67	0.52	1.69	1.34	0.09
Accrued Expenses	0.94	2.44	4.25	4.94	1.21	1.15
Current Portion of Leases	-	0.12	0.08	0.12	0.11	0.07
Total Current Liabilities	1.14	3.22	4.84	6.75	2.65	1.32
Long-Term Leases	-	0.21	0.32	0.09	0.24	0.36
Total Liabilities	1.14	3.43	5.15	6.84	2.89	1.67
Additional Paid-In Capital	120.98	116.16	105.68	101.26	97.64	34.5
Retained Earnings	-109.75	-102.62	-88.68	-63.82	-36.17	-23.7
Treasury Stock	-	-	-	-1.22	-	-
Total Common Equity	11.23	13.54	17	36.22	61.47	10.8
Shareholders' Equity	11.23	13.54	17	36.22	61.47	10.8
Total Liabilities & Equity	12.37	16.96	22.15	43.06	64.35	12.48
Total Debt	-	0.32	0.39	0.21	0.34	0.43
Net Cash (Debt)	10.06	13.94	19.39	39.68	60.82	11.27
Net Cash Growth	-47.17%	-28.10%	-51.13%	-34.76%	439.64%	-6.58%
Net Cash Per Share	1.67	3.11	6.60	13.95	23.45	6.59
Filing Date Shares Outstanding	6.16	4.71	3.55	2.76	2.85	-
Total Common Shares Outstanding	6.16	4.71	3.55	2.76	2.85	-
Working Capital	10.79	12.82	16.06	34.99	60.04	10.52
Book Value Per Share	1.82	2.87	4.79	13.11	21.56	-
Tangible Book Value	11.23	13.54	17	36.22	61.47	10.8
Tangible Book Value Per Share	1.82	2.87	4.79	13.11	21.56	-
Machinery	-	0.5	0.5	0.5	0.43	0.21
Leasehold Improvements	-	0.01	0.01	0.02	0.02	0.01

Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q